PharmaCorp Rx Inc. Stock: price and insider trades · Canada
PharmaCorp Rx Inc.: what insiders have been doing
PharmaCorp Rx Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. From 22 October 2025 to 22 October 2026, the disclosure feed for PharmaCorp Rx Inc. logged 35 filings by 6 insiders.
Only purchases show up on the open market, 6 purchases in all worth €67k, filed by 3 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €27k by Brownell, Kenneth Alva, published on 20 October 2026, equal to 0.052% of the market capitalisation. Those buying include 3 senior executives.
For context, the typical company on the same exchange (median of 2,472 companies) published 12 filings over the same period, against 35 filings here. Our records for PharmaCorp Rx Inc. go back to 2024, with 6 purchases and no sales on the open market in total.
The clock since the last published purchase (21 October 2026) now reads 19 days. The median gap between a trade and its publication by SEDI is 4 days. This delay matters because a trade only becomes useful information once it is public.
Other companies in the same sector with recent insider buying flagged by our signals: UCB. Source: insider filings from SEDI. Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 60,000 shares@ CA$0.41440.032% mcap2.2% of flowCommon SharesTSXSEDI:4793465Canonical exit: 18 Jan 2027 (T+90)
- 402 shares@ CA$0.410.0002% mcap0.0% of flowCommon SharesTSXSEDI:4793165Canonical exit: 14 Jan 2027 (T+90)
- 55,555 shares@ CA$0.41320.028% mcap2.1% of flowCommon SharesTSXSEDI:4793162Canonical exit: 14 Jan 2027 (T+90)
- 4,543 shares@ CA$0.4050.0023% mcap0.2% of flowCommon SharesTSXSEDI:4793160Canonical exit: 14 Jan 2027 (T+90)
- 100,000 shares@ CA$0.41890.052% mcap21.3% of flowCommon SharesTSXSEDI:4793076Canonical exit: 18 Jan 2027 (T+90)
- Common SharesTSXSEDI:4792663
- Common SharesTSXSEDI:4792657
- Warrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4792600
- WarrantsTSXSEDI:4792599
- 36,500 shares@ CA$0.40990.019% mcap2.0% of flowCommon SharesTSXSEDI:4792593Canonical exit: 14 Jan 2027 (T+90)
- Common SharesTSXSEDI:4792585
- Warrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4766946
- WarrantsTSXSEDI:4766945
- 173,333 shares@ CA$0.510.11% mcap100.0% of flowCommon SharesTSXSEDI:4752691
- 173,333 shares@ CA$0.510.11% mcap100.0% of flowCommon SharesTSXSEDI:4752685
- 173,333 shares@ CA$0.510.11% mcap100.0% of flowCommon SharesTSXSEDI:4752680
- 172,942 shares@ CA$0.510.11% mcap100.0% of flowCommon SharesTSXSEDI:4752673
- WarrantsTSXSEDI:4752540
- 17,353 shares@ CA$0.6037.0% of flowWarrantsTSXSEDI:4752538
- WarrantsTSXSEDI:4752537
- 34,706 shares@ CA$0.510.021% mcap63.0% of flowCommon SharesTSXSEDI:4752520
- 178,650 shares@ CA$0.4258.5% of flowCommon SharesTSXSEDI:4605982
- 59,524 shares@ CA$0.4219.5% of flowCommon SharesTSXSEDI:4605991
- 2,380,960 shares@ CA$0.4291.8% of flowCommon SharesTSXSEDI:4605976
- Common SharesTSXSEDI:4605990
25 of 36 declarations
About PharmaCorp Rx Inc.
PharmaCorp Rx Inc. is a company focused on the development and commercialization of pharmaceuticals. It is listed on the Toronto Stock Exchange (XTSE).
